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What’s in a name? A call to reframe non-communicable 
diseases
 The global health community does not spend much 
time on branding, which perhaps explains why existing 
classifi cations for the three largest groups of diseases are 
both outdated and counterproductive. The fi rst Global 
Burden of Disease study1 described infectious diseases, 
non-communicable diseases (NCDs), and injuries. This 
grouping refl ected a predominantly infectious disease 
burden in low-income and middle-income countries, 
which has since tilted towards NCDs. A name that is a 
longwinded non-defi nition, and that only tells us what 
this group of diseases is not, is not befi tting of a group 
of diseases that now constitute the world’s largest killer.  
NCDs—which include cancer, diabetes, chronic 
obstructive pulmonary disease, cardiovascular disease, 
and mental health conditions—are the leading cause 
of death worldwide2 and disproportionately affl  ict 
developing countries (unpublished). NCDs will cost 
the global economy US$47 trillion over the next 
two decades, and they continue to push millions of 
people into poverty.3 Nevertheless, NCDs receive the 
lowest overseas development assistance per disability-
adjusted life-year, and even the most cost-eff ective NCD 
interventions are severely underfunded compared with 
their infectious disease counterparts.4 What’s more, 
NCDs are under-represented in developing countries’ 
national health plans, undermining progress towards 
reaching universal health coverage and improvement of 
human capital.5 NCDs share all the ideological and social 
justice issues of HIV but cause 30 times more deaths and 
receive 17 times less funding.6 
The disproportionately low levels of national and 
international attention paid to NCDs in terms of action 
plans, funding, and global institutions might be partly 
attributable to the framing of these conditions. After 
all, “anything that begins with ‘non’ may be considered 
a ‘non-issue’ or a ‘non-starter’”.7 Evidence is mounting 
that some NCDs are partly or wholly communicable. 
They can be spread through social networks,8 viruses 
such as hepatitis and human papillomavirus, the built 
environment,9 cultural and economic conditions, 
food deserts (ie, areas short on fresh fruit, vegetables, 
and other healthy foods),10 and intergenerational 
transmission (ie, diabetes and obesity). Furthermore, the 
present misnomer implies that the causes are individual 
rather than societal. This implication is simply not the 
case: NCDs have largely sociogenetic antecedents, 
and eff orts focused on individual behaviour have little 
overall eff ect if the social and policy environments do 
not change in parallel.
The ongoing and largely unhelpful emphasis on 
individual healthy choices might hamper a shift towards 
more eff ective and equitable population-level policies 
such as tighter tobacco control and measures to address 
obesogenic environments. Unfortunately, system-wide 
socioeconomic drivers are diffi  cult to change and do not 
have the political expediency of blaming poor people 
for making poor decisions. Additionally, regulatory 
changes in tobacco, alcohol, and food policy can face 
stiff  opposition from powerful economic interests.
Calling the world’s biggest killer “non-communicable” 
propagates confusion, undermines eff orts to spur a 
sense of urgency, and defl ects attention from eff ective 
system-wide interventions. There have been repeated 
calls to rename NCDs and a widespread acceptance 
that the term is a poor fi t, but the lack of convincing 
alternatives and inertia stemming from widespread use 
seem unsurmountable. 
Renaming NCDs is not an issue of pedantry; it is an 
important means of consolidating the growing support 
for these ubiquitous conditions and invigorating 
the debate around interventions that stand the best 
chance of stemming the pandemic. The Sustainable 
Development Goals (SDGs) have cemented the 
importance of NCDs on the international agenda, and 
over the next few months the global health community 
will choose appropriate indicators for Goal 3. Now is 
the perfect time to refocus the global response through 
reframing the issue. Unless this long-debated issue of 
naming is comprehensively addressed, it will regularly 
resurface and might stand in the way of real progress. 
Although we are certain that the name NCD needs 
to go, we do not have a perfect alternative. We favour 
the terms societal and ecological (ie, the relation of 
living organisms to one another and to their physical 
surroundings) but hereby invite debate on the topic 
under the auspices of The Lancet Global Health. Online, 
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public, global forums—akin to the global dialogue of the 
Global Coordinating Mechanism on the Prevention and 
Control of NCDs and the 2 month online debate that 
followed, or the SDG indicator consultation—are setting 
new norms of transparency and inclusion of multiple 
stakeholders in important decision-making processes. 
What should this group of conditions be called? 
Should the lines be redrawn to include injuries? Is 
chronic a synonym? Are social injustice, globalisation, or 
socioeconomic transitions causative pathogens? 
Overall, this global consultative process should 
include not only the submission of new names but 
also a substantive discussion on the specifi c diseases 
and risks addressed. The new classifi cation could be 
institutionalised in the next version of the System of 
Health Accounts and the Organisation for Economic Co-
operation and Development’s Development Assistance 
Committee system (soon to include line items specifi c 
to chronic diseases), and potentially adopted by WHO 
in 2020, after the Global Action Plan for NCDs expires. 
We believe that this process has the potential to foster 
innovation, multisectoral action, and increased funding 
for the conditions that kill 38 million people each year. 
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